These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16097439)

  • 1. Combination of oral fluoropyrimidine and docetaxel: reappraisal of synergistic effect against gastric carcinoma xenografts.
    Kodera Y; Fujiwara M; Yokoyama H; Ohashi N; Miura S; Ito Y; Koike M; Ito K; Nakao A
    In Vivo; 2005; 19(5):861-6. PubMed ID: 16097439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of gene expression of thymidine phosphorylase, thymidylate synthase, dihydropyrimidine dehydrogenase after the administration of 5'-deoxy-5-fluorouridine, paclitaxel and its combination in human gastric cancer xenografts.
    Sakurai Y; Yoshida I; Kamoshida S; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Anticancer Res; 2008; 28(3A):1593-602. PubMed ID: 18630517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of combined administration of DPD-inhibitory oral fluoropyrimidine, S-1, plus paclitaxel on gene expressions of fluoropyrimidine metabolism-related enzymes in human gastric xenografts.
    Sakurai Y; Yoshida I; Kamoshida S; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Ann Surg Oncol; 2008 Aug; 15(8):2301-9. PubMed ID: 18506536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y; Harada K; Ferdous T; Yoshida H
    Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor efficacy of sequential treatment with docetaxel and 5-fluorouracil against human oral cancer cells.
    Tamatani T; Ferdous T; Takamaru N; Hara K; Kinouchi M; Kuribayashi N; Ohe G; Uchida D; Nagai H; Fujisawa K; Miyamoto Y
    Int J Oncol; 2012 Sep; 41(3):1148-56. PubMed ID: 22766915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts.
    Takechi T; Okabe H; Ikeda K; Fujioka A; Nakagawa F; Ohshimo H; Kitazato K; Fukushima M
    Oncol Rep; 2005 Jul; 14(1):33-9. PubMed ID: 15944764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.
    Sawada N; Ishikawa T; Fukase Y; Nishida M; Yoshikubo T; Ishitsuka H
    Clin Cancer Res; 1998 Apr; 4(4):1013-9. PubMed ID: 9563897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence on 5-fluorouracil metabolism by combination of interferon-alpha and 5-fluorouracil against human hepatocellular carcinoma xenografts].
    Jin CD; Yamamoto T; Nakamura M; Arai I; Kishin R; Xing X; Nagano H; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1511-5. PubMed ID: 15508442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schedule dependency of antitumor activity in combination therapy with capecitabine/5'-deoxy-5-fluorouridine and docetaxel in breast cancer models.
    Fujimoto-Ouchi K; Tanaka Y; Tominaga T
    Clin Cancer Res; 2001 Apr; 7(4):1079-86. PubMed ID: 11309360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines.
    Wada Y; Yoshida K; Suzuki T; Mizuiri H; Konishi K; Ukon K; Tanabe K; Sakata Y; Fukushima M
    Int J Cancer; 2006 Aug; 119(4):783-91. PubMed ID: 16557585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of capecitabine efficacy by oxaliplatin in human colorectal and gastric cancer xenografts.
    Sawada N; Kondoh K; Mori K
    Oncol Rep; 2007 Oct; 18(4):775-8. PubMed ID: 17786335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive interaction between lapatinib and capecitabine in human breast cancer models: study of molecular determinants.
    Chefrour M; Milano G; Formento P; Giacometti S; Denden A; Renée N; Iliadis A; Fischel JL; Ciccolini J
    Fundam Clin Pharmacol; 2012 Aug; 26(4):530-7. PubMed ID: 21623901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of antitumor activity of 5'-deoxy-5-fluorouridine (Furtulon) by taxane in human gastric cancer xenografts.
    Sawada N; Nose T; Ishikawa T; Yutaka T
    Oncol Rep; 2005 Jul; 14(1):53-7. PubMed ID: 15944767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models.
    Endo M; Shinbori N; Fukase Y; Sawada N; Ishikawa T; Ishitsuka H; Tanaka Y
    Int J Cancer; 1999 Sep; 83(1):127-34. PubMed ID: 10449619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of chemoresistance-related proteins in alpha-fetoprotein-producing adenocarcinoma of the digestive organs.
    Kamoshida S; Suzuki M; Sakurai Y; Ochiai M; Kimura F; Kuwao S; Sakamoto K; Sugimoto Y; Fukushima M; Tsutsumi Y
    Oncol Rep; 2006 Oct; 16(4):721-7. PubMed ID: 16969485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects.
    Blanquicett C; Saif MW; Buchsbaum DJ; Eloubeidi M; Vickers SM; Chhieng DC; Carpenter MD; Sellers JC; Russo S; Diasio RB; Johnson MR
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8773-81. PubMed ID: 16361565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of combination of S-1 and docetaxel on the human breast cancer xenograft transplanted into SCID mice.
    Suto A; Kubota T; Fukushima M; Ikeda T; Takeshita T; Ohmiya H; Kitajima M
    Oncol Rep; 2006 Jun; 15(6):1517-22. PubMed ID: 16685389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts.
    Ishikawa T; Sekiguchi F; Fukase Y; Sawada N; Ishitsuka H
    Cancer Res; 1998 Feb; 58(4):685-90. PubMed ID: 9485021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.